Effects of Abatacept in Patients With Early Rheumatoid Arthritis

NCT ID: NCT02504268

Last Updated: 2021-06-28

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

994 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-03

Study Completion Date

2020-03-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if abatacept is effective in the treatment of early rheumatoid arthritis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subcutaneous (SC)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Combination Therapy: Abatacept + Methotrexate

Abatacept 125 mg subcutaneous injection once per week + Methotrexate at least 15mg per week tablet or capsule orally once per week

Group Type EXPERIMENTAL

Abatacept

Intervention Type DRUG

Methotrexate

Intervention Type DRUG

Methotrexate treatment

Methotrexate at least 15mg per week tablet or capsule orally

Group Type ACTIVE_COMPARATOR

Methotrexate

Intervention Type DRUG

Abatacept Placebo

Placebo for Abatacept subcutaneous injection once per week

Group Type PLACEBO_COMPARATOR

Abatacept Placebo

Intervention Type OTHER

Methotrexate Placebo

Placebo to match Methotrexate capsule orally once per week

Group Type PLACEBO_COMPARATOR

Methotrexate Placebo

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Abatacept

Intervention Type DRUG

Methotrexate

Intervention Type DRUG

Abatacept Placebo

Intervention Type OTHER

Methotrexate Placebo

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Rheumatoid arthritis (RA) diagnosis less than 6 months
* CRP \> 3 mg/L or Erythrocyte Sedimentation Rate (ESR) ≥ 28 mm/h
* At least 3 swollen and 3 tender joints
* Anti-citrullinated protein antibodies (ACPA) positive

Exclusion Criteria

* At risk for tuberculosis
* Have acute infection
* Have chronic or recurrent bacterial or serious latent viral infection
* History of malignancies in the last 5 years except squamous skin, basal skin or cervical carcinoma
* Previous treatment with any conventional or biologic Disease-modifying anti rheumatic drugs (DMARD)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bristol-Myers Squibb

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bristol Myers Squibb

Role: STUDY_DIRECTOR

Bristol-Myers Squibb

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rheumatology Associates Of North Alabama, P.C.

Huntsville, Alabama, United States

Site Status

Arizona Arthritis & Rheumatology Research PLLC

Glendale, Arizona, United States

Site Status

Arizona Arthritis & Rheumatology Research PLLC

Mesa, Arizona, United States

Site Status

Arizona Arthritis & Rheumatology Research PLLC

Phoenix, Arizona, United States

Site Status

Arizona Arthritis & Rheumatology Research PLLC

Phoenix, Arizona, United States

Site Status

Arizona Arthritis & Rheumatology Research PLLC

Sun City, Arizona, United States

Site Status

CHI St. Vincent Medical Group Hot Springs

Hot Springs, Arkansas, United States

Site Status

Arkansas Primary Care Clinic

Little Rock, Arkansas, United States

Site Status

St. Joseph Heritage Medical Group

Fullerton, California, United States

Site Status

Healthcare Partners Medical Group

Huntington Beach, California, United States

Site Status

Valerius Medical Group and Research Center

Los Alamitos, California, United States

Site Status

Inland Rheumatology Clinical Trials Inc.

Upland, California, United States

Site Status

Joao Nascimento

Bridgeport, Connecticut, United States

Site Status

Rheumatology Associates Of Central Florida, P.A.

Orlando, Florida, United States

Site Status

Tampa Medical Group, Pa

Tampa, Florida, United States

Site Status

Coeur D'Alene Arthrit Clin

Coeur d'Alene, Idaho, United States

Site Status

Arthritis And Diabetes Clinic

Monroe, Louisiana, United States

Site Status

Klein And Associates, M.D., Pa

Hagerstown, Maryland, United States

Site Status

St. Paul Rheumatology, P.A.

Eagan, Minnesota, United States

Site Status

Arthritis Consultants

St Louis, Missouri, United States

Site Status

Physician Research Collaboration, Llc

Lincoln, Nebraska, United States

Site Status

Arthritis And Osteoporosis Associates, Pa

Freehold, New Jersey, United States

Site Status

Physicians Research Center, Llc

Toms River, New Jersey, United States

Site Status

Albuquerque Center For Rheumatology

Albuquerque, New Mexico, United States

Site Status

Albuquerque Clinical Trials

Albuquerque, New Mexico, United States

Site Status

Hospital For Special Surgery

New York, New York, United States

Site Status

Local Institution

Hickory, North Carolina, United States

Site Status

Pmg Research Of Salisbury

Salisbury, North Carolina, United States

Site Status

Carolina Arthritis Associates

Wilmington, North Carolina, United States

Site Status

Pmg Research Of Wilmington Llc

Wilmington, North Carolina, United States

Site Status

Health Research Of Oklahoma

Oklahoma City, Oklahoma, United States

Site Status

Oklahoma Ctr For Arthritis Therapy And Research, Inc.

Tulsa, Oklahoma, United States

Site Status

Altoona Center For Clinical Research

Duncansville, Pennsylvania, United States

Site Status

The Arthritis Group

Philadelphia, Pennsylvania, United States

Site Status

Clinical Research Center Of Reading, Llp

Wyomissing, Pennsylvania, United States

Site Status

West Tennessee Research Institute

Jackson, Tennessee, United States

Site Status

Metroplex Clinical Research Center

Dallas, Texas, United States

Site Status

Houston Institute For Clinical Research

Houston, Texas, United States

Site Status

Arthritis Clinic Of Northern Virginia, P.C.

Arlington, Virginia, United States

Site Status

Spectrum Medical, Inc.

Danville, Virginia, United States

Site Status

Arthritis Northwest

Spokane, Washington, United States

Site Status

Rheumatic Disease Center

Glendale, Wisconsin, United States

Site Status

Organizacion Medica De Investigacion S.A. (Omi)

Capital Federal, Buenos Aires, Argentina

Site Status

Local Institution

Ciudad Autonoma Beunos Aires, Buenos Aires, Argentina

Site Status

Hospital General De Agudos J.M. Ramos Mejia

Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina

Site Status

Framingham Centro Medico

La Plata, Buenos Aires, Argentina

Site Status

Instituto de Asistencia Reumatologica Integral

San Fernando, Buenos Aires, Argentina

Site Status

Caici

Rosario, Santa Fe Province, Argentina

Site Status

Instituto De Rehabilitacion Psicofisica

Buenos Aires, , Argentina

Site Status

Centro Consultora Integral de Salud SRL

Córdoba, , Argentina

Site Status

Hospital Privado-Centro Medico De Cordoba S.A.

Córdoba, , Argentina

Site Status

Centro De Investigaciones Reumatologicas

San Miguel de Tucumán, , Argentina

Site Status

Centro Medico Privado De Reumatologia

San Miguel de Tucumán, , Argentina

Site Status

Local Institution

Maroochydore, Queensland, Australia

Site Status

Local Institution

Southport, Queensland, Australia

Site Status

Local Institution

Hobart, Tasmania, Australia

Site Status

Local Institution

Camberwell, Victoria, Australia

Site Status

Local Institution

Coffs Harbour, , Australia

Site Status

Rheuma Zentrum Favoriten

Vienna, , Austria

Site Status

Local Institution

Juiz de Fora, Minas Gerais, Brazil

Site Status

Local Institution

Varginha, Minas Gerais, Brazil

Site Status

Local Institution

Curitiba, Paraná, Brazil

Site Status

Local Institution

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Local Institution

Santo André, São Paulo, Brazil

Site Status

Local Institution

São Paulo, , Brazil

Site Status

Local Institution

São Paulo, , Brazil

Site Status

Local Institution

São Paulo, , Brazil

Site Status

Local Institution

Winnipeg, Manitoba, Canada

Site Status

Local Institution

Montreal, Quebec, Canada

Site Status

Centre De Recherche Musculo-Squelettique

Trois-Rivières, Quebec, Canada

Site Status

Local Institution

Saskatchewan, Saskatchewan, Canada

Site Status

Centro Medico de Reumatologia Limitada

Temuco, Región de la Araucanía, Chile

Site Status

Centro De Estudios Reumatologicos

Santiago, Santiago Metropolitan, Chile

Site Status

Someal

Santiago, Santiago Metropolitan, Chile

Site Status

Centro de Investigacion en Reumatologia y Especialidades Medicas S.A.S

Bogotá, , Colombia

Site Status

Fundacion Instituto de Reumatologia Fernando Chalem

Bogotá, , Colombia

Site Status

Clinica de Artritis Temprana

Cali, , Colombia

Site Status

Hospital Pablo Tobon Uribe

Medellín, , Colombia

Site Status

Oddeleni klinicke farmakologie

Plzen-Bory, , Czechia

Site Status

Revmatologicky ustav

Prague, , Czechia

Site Status

MEDICAL PLUS, s.r.o.

Uherské Hradiště, , Czechia

Site Status

PV Medical Services, s.r.o.

Zlín, , Czechia

Site Status

Local Institution

Hyvinkää, , Finland

Site Status

Local Institution

Kuopio, , Finland

Site Status

Local Institution

Lyon, , France

Site Status

Local Institution

Orléans, , France

Site Status

Local Institution

Poitiers, , France

Site Status

Local Institution

Toulouse, , France

Site Status

Rheumapraxis Dr. Kurthen

Aachen, , Germany

Site Status

Charite Campus Mitte

Berlin, , Germany

Site Status

Rheumatologische Schwerpunktpraxis Dr. Zinke

Berlin, , Germany

Site Status

Immanuel Krankenhaus Berlin/Rheumaklinik Berlin Buch

Berlin, , Germany

Site Status

Schlosspark-Klinik

Berlin, , Germany

Site Status

Schwerpunktpraxis fuer Rheumatologie an den Kreiskliniken

Burghausen, , Germany

Site Status

Klinikum Der Albrecht-Ludwigs-Universitat

Freiburg im Breisgau, , Germany

Site Status

MVZ Rheuma

Hamburg, , Germany

Site Status

Hamburger Rheuma Forschungszentrum

Hamburg, , Germany

Site Status

Gemeinschaftspraxis Drs. von Hinueber u Demary

Hildesheim, , Germany

Site Status

Rheumatologie In Wuermtal

Planegg, , Germany

Site Status

Praxis Dr. Walter

Rendsburg, , Germany

Site Status

Local Institution

Budapest, , Hungary

Site Status

Belgyogy. Int. Reuma. DEOEC

Debrecen, , Hungary

Site Status

Vaszary Kolos Hospital

Esztergom, , Hungary

Site Status

Reumatologiai Osztaly Flor F.

Kistarcsa, , Hungary

Site Status

Reumatologiai Osztaly MAV

Szolnok, , Hungary

Site Status

Vital Medical Center

Veszprém, , Hungary

Site Status

Local Institution

Haifa, , Israel

Site Status

Local Institution

Petah Tikva, , Israel

Site Status

Local Institution

Ramat Gan, , Israel

Site Status

Local Institution

Tel Litwinsky, , Israel

Site Status

Local Institution

Zrifin, , Israel

Site Status

Ospedale Vittorio Emanuele

Catania, , Italy

Site Status

Istituto Gaetano Pini

Milan, , Italy

Site Status

Azienda Ospedaliera Luigi Sacco

Milan, , Italy

Site Status

Local Institution

Pavia, , Italy

Site Status

Local Institution

Roma, , Italy

Site Status

Ospedale Borgo Roma

Verona, , Italy

Site Status

Local Institution

Nagoya, Aichi-ken, Japan

Site Status

Local Institution

Nagoya, Aichi-ken, Japan

Site Status

Local Institution

Fukuoka, Fukuoka, Japan

Site Status

Local Institution

Kitakyushu-shi, Fukuoka, Japan

Site Status

Local Institution

Hiroshima, Hiroshima, Japan

Site Status

Local Institution

Sapporo, Hokkaido, Japan

Site Status

Local Institution

Sapporo, Hokkaido, Japan

Site Status

Local Institution

Sapporo, Hokkaido, Japan

Site Status

Local Institution

Kato-shi, Hyōgo, Japan

Site Status

Local Institution

Hitachi-Naka, Ibaraki, Japan

Site Status

Local Institution

Mito, Ibaraki, Japan

Site Status

Local Institution

Kagoshima, Kagoshima-ken, Japan

Site Status

Local Institution

Sagamihara-shi, Kanagawa, Japan

Site Status

Local Institution

Isahaya-shi, Nagasaki, Japan

Site Status

Local Institution

Sasebo-shi, Nagasaki, Japan

Site Status

Local Institution

Tomigusuku-shi, Okinawa, Japan

Site Status

Local Institution

Izumisano, Osaka, Japan

Site Status

Local Institution

Kawachi-Nagano, Osaka, Japan

Site Status

Local Institution

Iruma-gun, Saitama, Japan

Site Status

Local Institution

Kawagoe-shi, Saitama, Japan

Site Status

Local Institution

Sayama-shi, Saitama, Japan

Site Status

Local Institution

Hamamatsu, Shizuoka, Japan

Site Status

Local Institution

Chuo-ku, Tokyo, Japan

Site Status

Local Institution

Itabashi-ku, Tokyo, Japan

Site Status

Local Institution

Meguro-ku, Tokyo, Japan

Site Status

Local Institution

Meguro-ku, Tokyo, Japan

Site Status

Local Institution

Shinjuku-Ku, Tokyo, Japan

Site Status

Local Institution

Mexico City, Distrito Fededral, Mexico

Site Status

Local Institution

Mexicali, Estado de Baja California, Mexico

Site Status

Local Institution

León, Guanajuato, Mexico

Site Status

Local Institution

Guadalajara, Jalisco, Mexico

Site Status

Local Institution

Guadalajara, Jalisco, Mexico

Site Status

Local Institution

Guadalajara, Jalisco, Mexico

Site Status

Local Institution

Guadalajara, , Mexico

Site Status

Local Institution

México D.F., , Mexico

Site Status

Local Institution

San Luis Potosí City, , Mexico

Site Status

Local Institution

Monaco, , Monaco

Site Status

Local Institution

Leiden, , Netherlands

Site Status

Local Institution

Lima, , Peru

Site Status

Acq Medic Sac

Lima, , Peru

Site Status

Clinica El Golf

Lima, , Peru

Site Status

Instituto De Ginecologia Y Reproduccion Inv. Clinical Sac

Lima, , Peru

Site Status

Nszoz Unica Cr

Dąbrówka, , Poland

Site Status

Nzoz Mak Med

Nadarzyn, , Poland

Site Status

SANUS Szpital Specjalistyczny Sp. z o.o.

Stalowa Wola, , Poland

Site Status

Local Institution

Staszów, , Poland

Site Status

Slaski Szpital Reumatologiczno - Rehabilitacyjny

Ustroń, , Poland

Site Status

Instytut Reumatologii, I Klinika Reumatologii

Warsaw, , Poland

Site Status

Centrum Medyczne AMED Sp. z o.o.

Warsaw, , Poland

Site Status

Local Institution

Doha, , Qatar

Site Status

Local Institution

Bucharest, , Romania

Site Status

Local Institution

Bucharest, , Romania

Site Status

Local Institution

Cluj-Napoca, , Romania

Site Status

Local Institution

Moscow, , Russia

Site Status

Local Institution

Saint Petersburg, , Russia

Site Status

Local Institution

Saint Petersburg, , Russia

Site Status

Local Institution

Yaroslavl, , Russia

Site Status

Local Institution

Yekaterinburg, , Russia

Site Status

Local Institution

Singapore, , Singapore

Site Status

Local Institution

Singapore, , Singapore

Site Status

Local Institution

Port Elizabeth, Eastern Cape, South Africa

Site Status

Local Institution

Soweto, Gauteng, South Africa

Site Status

Local Institution

Cape Town, Western Cape, South Africa

Site Status

Local Institution

Pinelands, Cape Town, Western Cape, South Africa

Site Status

Local Institution

Stellenbosch, Western Cape, South Africa

Site Status

Local Institution

Anyang-si, Gyeonggi-do, South Korea

Site Status

Local Institution

Seongnam-si, Gyeonggi-do, South Korea

Site Status

Local Institution

Seoul, , South Korea

Site Status

Local Institution

A Coruña, , Spain

Site Status

Local Institution

Barcelona, , Spain

Site Status

Local Institution

Madrid, , Spain

Site Status

Local Institution

Madrid, , Spain

Site Status

Local Institution

Santiago Compostela, , Spain

Site Status

Local Institution

Gothenburg, , Sweden

Site Status

Local Institution

Malmo, , Sweden

Site Status

Local Institution

Stockholm, , Sweden

Site Status

Local Institution

Uppsala, , Sweden

Site Status

Local Institution

Tainan City, , Taiwan

Site Status

Local Institution

Taipei, , Taiwan

Site Status

Local Institution

Taipei, , Taiwan

Site Status

Local Institution

Taoyuan District, , Taiwan

Site Status

Local Institution

Leeds, North Yorkshire, United Kingdom

Site Status

Local Institution

Hull, , United Kingdom

Site Status

Local Institution

Manchester, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Austria Brazil Canada Chile Colombia Czechia Finland France Germany Hungary Israel Italy Japan Mexico Monaco Netherlands Peru Poland Qatar Romania Russia Singapore South Africa South Korea Spain Sweden Taiwan United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Emery P, Fleischmann R, Wong R, Lozenski K, Tanaka Y, Bykerk V, Bingham CO 3rd, Huizinga TWJ, Citera G, Perera V, Murthy B, Maxwell KF, Passarell J, Hedrich WD, Williams D. Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 Study. J Rheumatol. 2025 May 1;52(5):426-435. doi: 10.3899/jrheum.2024-0498.

Reference Type DERIVED
PMID: 39814436 (View on PubMed)

Emery P, Tanaka Y, Bykerk VP, Bingham CO, Huizinga TWJ, Citera G, Huang KG, Wu C, Connolly SE, Elbez Y, Wong R, Lozenski K, Fleischmann R. The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study. Arthritis Res Ther. 2023 Apr 22;25(1):67. doi: 10.1186/s13075-023-03038-2.

Reference Type DERIVED
PMID: 37087459 (View on PubMed)

Emery P, Tanaka Y, Bykerk VP, Huizinga TWJ, Citera G, Bingham CO 3rd, Banerjee S, Soule BP, Nys M, Connolly SE, Lozenski KL, Zhuo J, Wong R, Huang KG, Fleischmann R. Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis. Rheumatol Ther. 2023 Jun;10(3):707-727. doi: 10.1007/s40744-022-00519-9. Epub 2023 Mar 3.

Reference Type DERIVED
PMID: 36869251 (View on PubMed)

Wu C, Hu Y, Schafer P, Connolly SE, Wong R, Nielsen SH, Bay-Jensen AC, Emery P, Tanaka Y, Bykerk VP, Bingham CO, Huizinga TW, Fleischmann R, Liu J. Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD Open. 2022 Dec;8(2):e002683. doi: 10.1136/rmdopen-2022-002683.

Reference Type DERIVED
PMID: 36585217 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-001275-50

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

IM101-550

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Abatacept With Methotrexate- Phase IIB
NCT00162266 COMPLETED PHASE2
Methotrexate-Inadequate Response Study
NCT00559585 COMPLETED PHASE3